Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleSpecial Communication

Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers

Harland T. Holman, Michael J. Bouthillier and Frank Müller
The Journal of the American Board of Family Medicine April 2023, 36 (2) 356-359; DOI: https://doi.org/10.3122/jabfm.2022.220292R2
Harland T. Holman
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Bouthillier
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Müller
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Dry Powder, Soft Mist, and Nebulization Solutions Available in the US

    Generic Drug NameBrand Names*
    Short-Acting Beta2-Agonists (SABA)
    LevalbuterolXopenex and generic (Neb)
    Albuterol (Salbutamol)ProAir Digihaler, ProAir RespiClick, and generic (Neb)
    Long-Acting Beta2-Agonists (LABA)
    FormoterolPerforomist and generic (Neb)
    ArformoterolBrovana and generic (Neb)
    SalmeterolSerevent Diskus
    OlodaterolStriverdi Respimat
    Corticosteroids
    BudesonidePulmicort Flexhaler, generic (Neb)
    Fluticasone furoateArnuity Ellipta
    Fluticasone propionateFlovent Diskus, ArmonAir Digihaler, RespiClick
    MometasoneAsmanex Twisthaler
    Combination of Long-Acting Beta2-Agonists + Corticosteroid (LABA/ICS)
    Salmeterol/fluticasone propionateAdvair Diskus, Airduo Digihaler, Wixela Inhub
    VilanteroI/fluticasone furoateBreo Ellipta and generic
    Short-acting Anticholinergics (SAMA)
    lpratropium bromideAtrovent and generic (Neb)
    Long-acting Anticholinergics (LAMA)
    Aclidinium bromideTudorza Pressair
    Glycopyrronium bromideLonhala Magnai (Neb)
    RevefenacinYupelri (Neb)
    TiotropiumSpiriva HandiHaler, Spiriva Respimat (SMI)
    UmeclidiniumIncruse Ellipta
    Combination Short-Acting Beta2-Agonists + Short-acting Anticholinergics (SABA/SAMA)
    Albuterol/ipratropiumCombivent Respimat (SMI), Duoneb and generic (Neb)
    Combination Long-Acting Beta2-Agonists + Long-acting Anticholinergics (LABA/LAMA)
    Formoterol/aclidiniumDuaklir Pressair
    Vilanterol/umeclidiniumAnoro Ellipta
    Olodaterol/tiotropiumStiolto Respimat (SMI)
    Triple Combination (LABA/LAMA/ICS)
    Fluticasone/umeclidinium/vilanterolTrelegy Ellipta
    • ↵* Products are Dry Powder Inhalation formulations unless otherwise specified.

    • Abbreviations: SMI, soft mist inhaler, Neb, Nebulization solution.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 36 (2)
The Journal of the American Board of Family Medicine
Vol. 36, Issue 2
March/April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
Harland T. Holman, Michael J. Bouthillier, Frank Müller
The Journal of the American Board of Family Medicine Apr 2023, 36 (2) 356-359; DOI: 10.3122/jabfm.2022.220292R2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
Harland T. Holman, Michael J. Bouthillier, Frank Müller
The Journal of the American Board of Family Medicine Apr 2023, 36 (2) 356-359; DOI: 10.3122/jabfm.2022.220292R2
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Teaching Point of Significant Clinical Relevance
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey
  • Primary Care Clinicians Attitude, Knowledge, and Willingness to Address Climate Change in Shared Decision-Making
  • Research Representing the Changing Landscape of Family Medicine
  • Google Scholar

More in this TOC Section

  • In Defense of Generalists: Primary Care Observations Have Systematic Advantages
  • Looking Back to Move Forward: Reflections of PBRN Directors
  • Building a Primary Care Research Agenda for Latino Populations in the Setting of the Latino Paradox: A Report from the 2023 Latino Primary Care Summit
Show more Special Communication

Similar Articles

Keywords

  • Asthma
  • Carbon Dioxide
  • Carbon Footprint
  • Climate Change
  • COPD
  • Drug Prescriptions
  • Dry Powder Inhalers
  • Environmental Medicine
  • Family Medicine
  • Global Warming
  • Greenhouse Gases
  • Metered Dose Inhalers
  • Norflurane

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire